Page last updated: 2024-10-25

clonidine and Disorders of Excessive Somnolence

clonidine has been researched along with Disorders of Excessive Somnolence in 4 studies

Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.

Disorders of Excessive Somnolence: Disorders characterized by hypersomnolence during normal waking hours that may impair cognitive functioning. Subtypes include primary hypersomnia disorders (e.g., IDIOPATHIC HYPERSOMNOLENCE; NARCOLEPSY; and KLEINE-LEVIN SYNDROME) and secondary hypersomnia disorders where excessive somnolence can be attributed to a known cause (e.g., drug affect, MENTAL DISORDERS, and SLEEP APNEA SYNDROME). (From J Neurol Sci 1998 Jan 8;153(2):192-202; Thorpy, Principles and Practice of Sleep Medicine, 2nd ed, p320)

Research Excerpts

ExcerptRelevanceReference
"Tizanidine HCl is an alpha2 adrenergic agonist indicated for treating spasticity due to MS or spinal cord injury."6.75Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety. ( Auriel, E; Karni, A; Vakhapova, V, 2010)
"Tizanidine HCl is an alpha2 adrenergic agonist indicated for treating spasticity due to MS or spinal cord injury."2.75Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety. ( Auriel, E; Karni, A; Vakhapova, V, 2010)
" Blood samples were collected to determine plasma tizanidine pharmacokinetic profiles, and computerized cognitive function tests were performed that yielded a validated composite score, Power of Attention, an index of sedation."2.72Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. ( Henney, HR; Kovelesky, RA; Shah, J; Wesnes, KA, 2006)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (75.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vakhapova, V1
Auriel, E1
Karni, A1
Marui, S1
Oliveira, CH1
Souza, SC1
Berger, K1
Khawali, C1
Hauache, OM1
Maciel, RM1
Vieira, JG1
Shah, J1
Wesnes, KA1
Kovelesky, RA1
Henney, HR1
Shiber, J1
Fontane, E1
Rosier, M1

Trials

2 trials available for clonidine and Disorders of Excessive Somnolence

ArticleYear
Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
    Clinical neuropharmacology, 2010, Volume: 33, Issue:3

    Topics: Administration, Sublingual; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult;

2010
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Clinical therapeutics, 2006, Volume: 28, Issue:9

    Topics: Adolescent; Adult; Capsules; Clonidine; Cognition; Cross-Over Studies; Disorders of Excessive Somnol

2006

Other Studies

2 other studies available for clonidine and Disorders of Excessive Somnolence

ArticleYear
[Tolerance of the oral clonidine test in 180 patients: efficacy of the volemic expantion in controlling arterial hypotension].
    Arquivos brasileiros de endocrinologia e metabologia, 2005, Volume: 49, Issue:4

    Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Child; Child, Preschool; Clonidine; Disorders of Exces

2005
A 6-year-old girl with somnolence: patching together the clues.
    Pediatric emergency care, 2007, Volume: 23, Issue:12

    Topics: Child; Clonidine; Disorders of Excessive Somnolence; Emergency Service, Hospital; Female; Humans; Sy

2007